It has not been well known about the changes of bone metabolic markers, bone mineral density and other bone-related markers after teriparatide and/or denosumab treatment in Japanese osteoporotic patients.
Inclusion Criteria:
Exclusion Criteria:
yxn14@aol.jp+81-263-37-2659